Impact of Epigenetic Therapy Versus Conventional Chemotherapy on Survival of Elderly Patients with Acute Myeloid Leukemia

被引：0
|
作者：
Quintas-Cardama, Alfonso
Kantarjian, Hagop M. [1 ]
Garcia-Manero, Guillermo
Ravandi, Farhad [1 ]
Brandt, Mark [1 ]
Faderl, Stefan [1 ]
Pierce, Sherry
Borthakur, Gautam [1 ]
Cortes, Jorge E. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：648 / 649
页数：2
相关论文
共 50 条
  • [41] Acute myeloid leukemia in HIV positive patients: Response to conventional chemotherapy.
    Sutton, L
    Lortholary, O
    Rio, B
    Dhedin, N
    Bouabdallah, R
    Dombret, H
    Fouillard, L
    Thomas, X
    Witz, B
    Casassus, P
    BLOOD, 1995, 86 (10) : 3725 - 3725
  • [42] Use of gemtuzumab ozogamycin combined with conventional chemotherapy in patients with acute myeloid leukemia
    Perini, Guilherme Fleury
    de Souza Santos, Fabio Pires
    Esteves, Iracema
    Bley do Nascimento, Claudia Mac-Donald
    Rodrigues, Morgani
    de Assis, Reijane Alves
    Helman, Ricardo
    Kutner, Jose Mauro
    Feitosa Ribeiro, Andreza Alice
    Hamerschlak, Nelson
    EINSTEIN-SAO PAULO, 2011, 9 (02): : 190 - 195
  • [43] Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia
    Baz, Rachid
    Rodriguez, Cristina
    Fu, Alex Z.
    Jawde, Rony Abou
    Kalaycio, Matt
    Advani, Anjali
    Sobecks, Ronald
    Sekeres, Mikkael A.
    CANCER, 2007, 110 (08) : 1752 - 1759
  • [44] REMISSION RATE AND SURVIVAL IN ACUTE MYELOID-LEUKEMIA - IMPACT OF SELECTION AND CHEMOTHERAPY
    WAHLIN, A
    HORNSTEN, P
    JONSSON, H
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1991, 46 (04) : 240 - 247
  • [45] Comorbidity as a risk factor for overall survival and decision criteria for intensity of chemotherapy in elderly patients with acute myeloid leukemia
    Djunic, Irena
    Virijevic, Marijana
    Novkovic, Aleksandra
    Djurasinovic, Vladislava
    Colovic, Natasa
    Vidovic, Ana
    Suvajdzic-Vukovic, Nada
    Tomin, Dragica
    MEDICAL ONCOLOGY, 2012, 29 (02) : 1077 - 1081
  • [46] Comorbidity as a risk factor for overall survival and decision criteria for intensity of chemotherapy in elderly patients with acute myeloid leukemia
    Irena Djunic
    Marijana Virijevic
    Aleksandra Novkovic
    Vladislava Djurasinovic
    Natasa Colovic
    Ana Vidovic
    Nada Suvajdzic-Vukovic
    Dragica Tomin
    Medical Oncology, 2012, 29 : 1077 - 1081
  • [47] Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia
    Ciftciler, Rafiye
    Demiroglu, Haluk
    Haznedaroglu, Ibrahim Celalettin
    Sayinalp, Nilgun
    Aksu, Salih
    Ozcebe, Osman
    Goker, Hakan
    Aydin, Muruvvet Seda
    Buyukasik, Yahya
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (11): : 729 - 734
  • [48] Epigenetic therapy of myelodysplastic syndromes and acute myeloid leukemia
    Voso, Maria Teresa
    Lo-Coco, Francesco
    Fianchi, Luana
    CURRENT OPINION IN ONCOLOGY, 2015, 27 (06) : 532 - 539
  • [49] EPIGENETIC THERAPY FOR TREATMENT PEDIATRIC ACUTE MYELOID LEUKEMIA
    Nemirovchenko, V.
    Popa, A.
    Mentkevich, G.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S322 - S323
  • [50] Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients 60 years old
    Gupta, Neha
    Miller, Austin
    Gandhi, Shipra
    Ford, Laurie A.
    Vigil, Carlos E.
    Griffiths, Elizabeth A.
    Thompson, James E.
    Wetzler, Meir
    Wang, Eunice S.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (07) : 639 - 646
12345